GHENT, Belgium, Oct. 28, 2013 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX] today announced that pre-clinical proof-of-concept data from ALX-0761, a Nanobody® partnered with Merck Serono, will be presented at the Annual Meeting of the American College of Rheumatology (ACR), 26 to 30 October 2013, San Diego, California.
Help employers find you! Check out all the jobs and post your resume.
